 |
| Defibrillators Market |
Defibrillators Market by Product
(Implantable Defibrillators and External Defibrillators) and End User
(Hospital, Pre Hospital, Public Access Market, Alternative Care, and Home) and
by Region (North America, Latin America, Asia Pacific, Europe, Middle East, and
Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030
Global Defibrillators
Market is estimated to be valued at US$ 16,843.5 million in 2022 and is expected to exhibit a CAGR of 5.7% during the forecast
period (2022-2030).
Market Overview:
Defibrillators are equipment that send an
electric pulse or shock to the cardiac to restore a normal heartbeat. They are utilized to
inhibit or correct an arrhythmia, an irregular pulse rate that is very slow or very
fast. A defibrillator can save the life if one is suffering from cardiac
arrest. This device offers an electrical charge that obstructs the heart's
abnormal rhythm so the heart can regain a normal rhythm. Even with
defibrillation, heart attack is deadly for several people.
Competitive
Landscape:
Key players involved in the growth of global Defibrillators
Market are
Mediana Co. Ltd, CU Medical System Inc., Asahi Kasei Corporation, Koninklijke
Philips NV, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd, ViVest
Medical, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Schiller AG, Stryker
Corporation, and Others.
Market Key Drivers:
Rising prevalence of cardiac disorders is
expected to boost the growth of global Defibrillators Market. For instance, as
per BHF about 110 million men and 80 million women suffer from coronary heart
disease.
Increasing technological developments and regulatory
initiatives is projected to propel the growth of global defibrillators market.
For instance, in March 2021, the Government House in Australia introduced the
St. John-branded public access defibrillator.
Covid-19 Impact
Analysis:
The COVID-19 outbreak had a significant effect
on the growth of the global defibrillator market. This was owing to the rescheduling
of heart surgeries and the deduction in the cardiac surgery volume owing to the
stringent rules imposed by several regulatory throughout the pandemic. As per
NCBI in July 2021, there was a 52.7% decrease in adult cardiac surgery volume
in the U.S in the first half of 2020.
Key Takeaways:
The global defibrillator market is
anticipated to exhibit a CAGR of 7.63 % during the forecast period rising
product launches and approvals in October 2021, CellAED introduced the portable,
smart personal automated external defibrillator, which is accessible for
pre-order in Europe.
Among regions, North America, Europe and Asia
Pacific are expected to witness robust growth in the global defibrillator
market due to mergers and acquisitions, product expansions and rising use of
AI/ML, increasing cardiovascular diseases, Atrial fibrillation, increasing
geriatric population. For instance, as per Statistics Canada in August 2022 the
population aged 70 to 74 years in Canada was 1,847,585 while the population
aged 80 to 84 years was 840,545.